Patents by Inventor Marc Antoine Perrin

Marc Antoine Perrin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparation of crystal forms of 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxidopyridyn-4-yl)-5-methoxypyridine-2-carboxamide and crystal forms thereof
    Patent number: 9533953
    Abstract: The present invention relates to a process of preparation of Crystal Forms of 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-methoxypyridine-2-carboxamide of formula (I), said Crystal Forms which are designated as Crystal Forms A to I A and their use as a medicament.
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: January 3, 2017
    Assignee: SANOFI
    Inventors: Pascal Billot, Didier Brige, Alexandre Giuliani, Hagit Elmaleh, Marc-Antoine Perrin
  • Polymorph of -(3-{[(2)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide
    Patent number: 9388143
    Abstract: Provided herein are various polymorph forms of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: July 12, 2016
    Assignee: SANOFI
    Inventors: Virginie Baulier, Matthieu Fugier, Stephane Kozlovic, Marc-Antoine Perrin, Bruno Baillon, Myriam Comte
  • METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-YL)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF
    Publication number: 20150322014
    Abstract: The present invention relates to a process of preparation of Crystal Forms of 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-methoxypyridine-2-carboxamide of formula (I), said Crystal Forms which are designated as Crystal Forms A to I A and their use as a medicament.
    Type: Application
    Filed: November 28, 2013
    Publication date: November 12, 2015
    Inventors: Pascal BILLOT, Didier BRIGE, Alexandre GIULIANI, Hagit ELMALEH, Marc-Antoine PERRIN
  • CRYSTALLINE COMPOUNDS
    Publication number: 20150183752
    Abstract: Provided herein are various polymorph forms of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide.
    Type: Application
    Filed: March 12, 2015
    Publication date: July 2, 2015
    Inventors: Virginie BAULIER, Matthieu FUGIER, Stephane KOZLOVIC, Marc-Antoine PERRIN, Bruno BAILLON, Myriam COMTE
  • Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride
    Publication number: 20080051382
    Abstract: The invention relates to novel crystalline forms of 3-beta-amino-17-methylene-androstane-6-alpha,7-beta-diol hydrochloride, referred to as form A, form B and form C, a method for preparing same, the use thereof as a drug, and pharmaceutical compositions containing same.
    Type: Application
    Filed: October 20, 2004
    Publication date: February 28, 2008
    Applicant: INFLAZYME PHARMACEUTICALS LTD.
    Inventors: Colette Colladant, Denis Prat, Pascal Billot, Alexandre Giuliani, Hagit Elnaleh, Marc-Antoine Perrin
  • Acetone solvate of dimethoxy docetaxel and its process of preparation
    Patent number: 7241907
    Abstract: This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?,10?-dimethoxy-9-oxotax-11-en-13?-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: July 10, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Didier, Marc-Antoine Perrin
  • Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
    Patent number: 6982334
    Abstract: The present invention comprises crystalline forms of 3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structure: and as characterized herein by powder X-ray diffraction patterns as form A and form B, processes for preparing form A from the purified amorphous form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, a processes for preparing form A by heating monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, a pharmaceutical composition comprising form A, a pharmaceutical composition comprising form A and form B or monohydrated form C, a pharmaceutical composition comprising form A, form B and monohydrated form C, a method for treating a bacterial infection with form A, a method for treating a bacterial infection with form A and form B or monohydrated form C, and a method f
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: January 3, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Jacques Bourget, Marc Antoine Perrin, Serge Mignani, Bernd Janocha, Michel Cheve, Carole Neves, Pascal Billot, Michel Tabart, Sylvaine Lafont
  • Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6 methoxyquinolin-4-propyl]-1-[2-2-thienylthio)ethyl] piperidine-3-carboxylic acid
    Patent number: 6939970
    Abstract: The present invention comprises monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structure and as herein defined by powder X-ray diffraction, processes for preparing monohydrated form C from amorphorous (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid or form A of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, pharmaceutical compositions comprising monohydrated form C, pharmaceutical compositions comprising monohydrated form C and form A or form B of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, pharmaceutical compositions comprising monohydrated form C, form A and form B, methods for treating bacterial infection with monohydrated form C, methods for treating bacterial infection with monohydrated form
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: September 6, 2005
    Assignee: Aventis Pharma S. A.
    Inventors: Jacques Bourget, Marc Antoine Perrin, Bernd Janocha, Carole Neves, Pascal Billot, Sylvaine Lafont
  • Acetone solvate of dimethoxy docetaxel and its process of preparation
    Publication number: 20050065138
    Abstract: This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?,10?-dimethoxy-9-oxotax-11-en-13?-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
    Type: Application
    Filed: September 17, 2004
    Publication date: March 24, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Eric Didier, Marc-Antoine Perrin
  • Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxy-quinolin-4-yl)propyl]-1-[2-2thienylthio)ethyl] piperidine-3-carboxylic acid
    Publication number: 20040147554
    Abstract: The present invention comprises monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structure 1
    Type: Application
    Filed: December 18, 2003
    Publication date: July 29, 2004
    Applicant: Aventis Pharms S.A.
    Inventors: Jacques Bourget, Marc Antoine Perrin, Bernd Janocha, Carole Neves, Pascal Billot, Sylvaine Lafont
  • Crystalline form of (3R,4R)-4-[3-(S)-Hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
    Publication number: 20040147751
    Abstract: The present invention comprises crystalline forms of 3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structure: 1
    Type: Application
    Filed: December 18, 2003
    Publication date: July 29, 2004
    Applicant: Aventis Pharma S. A.
    Inventors: Jacques Bourget, Marc Antoine Perrin, Serge Mignani, Bernd Janocha, Michel Cheve, Carole Neves, Pascal Billot, Michel Tabart, Sylvaine Lafont